These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25359591)

  • 1. Immunogenicity and efficacy of fowlpox-vectored and inactivated avian influenza vaccines alone or in a prime-boost schedule in chickens with maternal antibodies.
    Richard-Mazet A; Goutebroze S; Le Gros FX; Swayne DE; Bublot M
    Vet Res; 2014 Oct; 45(1):107. PubMed ID: 25359591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and use of fowlpox vectored vaccines for avian influenza.
    Bublot M; Pritchard N; Swayne DE; Selleck P; Karaca K; Suarez DL; Audonnet JC; Mickle TR
    Ann N Y Acad Sci; 2006 Oct; 1081():193-201. PubMed ID: 17135511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements to the hemagglutination inhibition test for serological assessment of recombinant fowlpox-H5-avian-influenza vaccination in chickens and its use along with an agar gel immunodiffusion test for differentiating infected from noninfected vaccinated animals.
    Swayne DE; Avellaneda G; Mickle TR; Pritchard N; Cruz J; Bublot M
    Avian Dis; 2007 Sep; 51(3):697-704. PubMed ID: 17992929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.
    Niqueux E; Guionie O; Amelot M; Jestin V
    Vaccine; 2013 Aug; 31(38):4121-8. PubMed ID: 23845804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge.
    Steensels M; Van Borm S; Lambrecht B; De Vriese J; Le Gros FX; Bublot M; van den Berg T
    Avian Dis; 2007 Mar; 51(1 Suppl):325-31. PubMed ID: 17494576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Bertran K; Lee DH; Criado MF; Balzli CL; Killmaster LF; Kapczynski DR; Swayne DE
    Vaccine; 2018 Oct; 36(43):6361-6372. PubMed ID: 30241684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High level of protection induced by two fowlpox vector vaccines against a highly pathogenic avian influenza H5N1 challenge in specific-pathogen-free chickens.
    Bublot M; Manvell RJ; Shell W; Brown IH
    Avian Dis; 2010 Mar; 54(1 Suppl):257-61. PubMed ID: 20521642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus.
    Kilany WH; Hassan MK; Safwat M; Mohammed S; Selim A; VonDobschuetz S; Dauphin G; Lubroth J; Jobre Y
    Avian Pathol; 2015 Oct; 44(5):333-41. PubMed ID: 26023824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of poxvirus vector avian influenza vaccines in Muscovy and Pekin ducks.
    Bublot M; Richard-Mazet A; Chanavat-Bizzini S; Le Gros FX; Duboeuf M; Stoll A; Palfi V; Niqueux E; Guionie O; Dren N
    Avian Dis; 2010 Mar; 54(1 Suppl):232-8. PubMed ID: 20521637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stronger Interference of Avian Influenza Virus-Specific Than Newcastle Disease Virus-Specific Maternally Derived Antibodies with a Recombinant NDV-H5 Vaccine.
    Lardinois A; Vandersleyen O; Steensels M; Desloges N; Mast J; van den Berg T; Lambrecht B
    Avian Dis; 2016 May; 60(1 Suppl):191-201. PubMed ID: 27309055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI.
    Steensels M; Bublot M; Van Borm S; De Vriese J; Lambrecht B; Richard-Mazet A; Chanavat-Bizzini S; Duboeuf M; Le Gros FX; van den Berg T
    Vaccine; 2009 Jan; 27(5):646-54. PubMed ID: 19056442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge.
    Bublot M; Pritchard N; Cruz JS; Mickle TR; Selleck P; Swayne DE
    Avian Dis; 2007 Mar; 51(1 Suppl):498-500. PubMed ID: 17494618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza.
    Swayne DE
    Ann N Y Acad Sci; 2006 Oct; 1081():174-81. PubMed ID: 17135509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.
    Rauw F; Palya V; Gardin Y; Tatar-Kis T; Dorsey KM; Lambrecht B; van den Berg T
    Avian Dis; 2012 Dec; 56(4 Suppl):913-22. PubMed ID: 23402112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of single 1-day-old chick vaccination using a Newcastle disease virus vector with a prime/boost vaccination scheme against a highly pathogenic avian influenza H5N1 challenge.
    Ferreira HL; Rauw F; Pirlot JF; Reynard F; van den Berg T; Bublot M; Lambrecht B
    Avian Pathol; 2014; 43(1):68-77. PubMed ID: 24320551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against H7N3 high pathogenicity avian influenza in chickens immunized with a recombinant fowlpox and an inactivated avian influenza vaccines.
    Bertran K; Sá E Silva M; Pantin-Jackwood MJ; Swayne DE
    Vaccine; 2013 Aug; 31(35):3572-6. PubMed ID: 23707445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
    Kapczynski DR; Pantin-Jackwood MJ; Spackman E; Chrzastek K; Suarez DL; Swayne DE
    Vaccine; 2017 Nov; 35(46):6345-6353. PubMed ID: 28456525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive protection afforded by maternally-derived antibodies in chickens and the antibodies' interference with the protection elicited by avian influenza-inactivated vaccines in progeny.
    De Vriese J; Steensels M; Palya V; Gardin Y; Dorsey KM; Lambrecht B; Van Borm S; van den Berg T
    Avian Dis; 2010 Mar; 54(1 Suppl):246-52. PubMed ID: 20521640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1.
    Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
    Vet Microbiol; 2012 Feb; 155(1):13-20. PubMed ID: 21920677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.